Literature DB >> 16271016

Multiplex-PCR assay for the deletions causing hereditary persistence of fetal hemoglobin.

Urvashi Bhardwaj1, Edward R B McCabe.   

Abstract

INTRODUCTION: Hereditary persistence of fetal hemoglobin (HPFH) is a benign condition caused by the failure of normal switching from the fetal to the adult beta-globin gene, resulting in continuous production of fetal hemoglobin beyond the perinatal period. To date, eight deletions of variable size and position have been reported for HPFH. Southern hybridization and PCR are the most common methods used to detect each deletion. AIM: Our aim was to develop a multiplex-PCR assay to detect these deletions in a single tube in order to facilitate rapid and accurate molecular diagnosis. METHODS AND
RESULTS: This report is the first application of multiplex-gap-PCR to detect all HPFH deletions simultaneously to expedite diagnosis. The deletion breakpoints were precisely identified for each deletion and primers were designed in the unique regions across the breakpoints of HPFH-1 (Black), HPFH-2 (Ghanaian), HPFH-3 (Asian Indian), HPFH-4 (Italian), HPFH-5 (Italian), HPFH-6 (Vietnamese), HPFH-7 (Kenyan), and SEA-HPFH (Southeast Asian). As many as 16 primers were used in a single amplification reaction by adjusting the relative primer concentrations. The multiplex-PCR approach was standardized on known positive control samples. We identified unique deletion-specific products for each deletion. The results were confirmed by sequence analysis.
CONCLUSIONS: We conclude that our multiplex-gap PCR strategy provides the most rapid and accurate diagnosis for the deletions in the beta-globin gene cluster causing HPFH.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16271016     DOI: 10.1007/bf03260083

Source DB:  PubMed          Journal:  Mol Diagn        ISSN: 1084-8592


  23 in total

1.  Intergenic transcription and developmental remodeling of chromatin subdomains in the human beta-globin locus.

Authors:  J Gribnau; K Diderich; S Pruzina; R Calzolari; P Fraser
Journal:  Mol Cell       Date:  2000-02       Impact factor: 17.970

2.  Molecular cloning of the breakpoints of the hereditary persistence of fetal hemoglobin type-6 (HPFH-6) deletion and sequence analysis of the novel juxtaposed region from the 3' end of the beta-globin gene cluster.

Authors:  T Kosteas; A Palena; N P Anagnou
Journal:  Hum Genet       Date:  1997-09       Impact factor: 4.132

3.  A new hereditary persistence of fetal hemoglobin deletion has the breakpoint within the 3' beta-globin gene enhancer.

Authors:  C Camaschella; A Serra; E Gottardi; A Alfarano; D Revello; U Mazza; G Saglio
Journal:  Blood       Date:  1990-02-15       Impact factor: 22.113

4.  Italian type of deletional hereditary persistence of fetal hemoglobin.

Authors:  G Saglio; C Camaschella; A Serra; T Bertero; G Rege Cambrin; A Guerrasio; U Mazza; P Izzo; F Terragni; B Giglioni
Journal:  Blood       Date:  1986-09       Impact factor: 22.113

Review 5.  Hemoglobin switching and fetal hemoglobin reactivation.

Authors:  J M Cunningham; S M Jane
Journal:  Semin Hematol       Date:  1996-01       Impact factor: 3.851

6.  The deletion in both common types of hereditary persistence of fetal hemoglobin is approximately 105 kilobases.

Authors:  F S Collins; J L Cole; W K Lockwood; M C Iannuzzi
Journal:  Blood       Date:  1987-12       Impact factor: 22.113

7.  The breakpoint of a large deletion causing hereditary persistence of fetal hemoglobin occurs within an erythroid DNA domain remote from the beta-globin gene cluster.

Authors:  E A Feingold; B G Forget
Journal:  Blood       Date:  1989-11-01       Impact factor: 22.113

8.  [Estimation of the frequency of Hereditary Persistence of Fetal Hemoglobin in Brazil].

Authors:  Vânia Aparecida da Costa; Maria Júlia Acedo; Newton Carlos Polimeno; Carmen Sílvia Bertuzzo
Journal:  Cad Saude Publica       Date:  2002 Sep-Oct       Impact factor: 1.632

9.  Molecular analysis of deletions in the human beta-globin gene cluster: deletion junctions and locations of breakpoints.

Authors:  P S Henthorn; O Smithies; D L Mager
Journal:  Genomics       Date:  1990-02       Impact factor: 5.736

10.  Interpretation of fetal hemoglobin only on newborn screening for hemoglobinopathy.

Authors:  Matthew M Heeney; Kathleen Delgrosso; Robbi Robinson; Christine A Johnson; Charles W Daeschner; Thomas A Campbell; Saul Surrey; Russell E Ware
Journal:  J Pediatr Hematol Oncol       Date:  2002 Aug-Sep       Impact factor: 1.289

View more
  3 in total

Review 1.  Natural Remedies for the Treatment of Beta-Thalassemia and Sickle Cell Anemia-Current Status and Perspectives in Fetal Hemoglobin Reactivation.

Authors:  Noel Yat Hey Ng; Chun Hay Ko
Journal:  Int Sch Res Notices       Date:  2014-10-02

2.  Fetal Hemoglobin Inducers from the Natural World: A Novel Approach for Identification of Drugs for the Treatment of {beta}-Thalassemia and Sickle-Cell Anemia.

Authors:  Nicoletta Bianchi; Cristina Zuccato; Ilaria Lampronti; Monica Borgatti; Roberto Gambari
Journal:  Evid Based Complement Alternat Med       Date:  2007-12-11       Impact factor: 2.629

3.  β‑thalassemia caused by compound heterozygous mutations and cured by bone marrow transplantation: A case report.

Authors:  Liusong Wu; Zhiyu Peng; Sen Lu; Mei Tan; Ying Rong; Runmei Tian; Yuhang Yang; Yan Chen; Jindong Chen
Journal:  Mol Med Rep       Date:  2017-09-12       Impact factor: 2.952

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.